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Abstract 
Disposable technology has gained increasing acceptance in the biopharmaceutical industry over 
the last decade, and provides many advantages over conventional stainless steel equipment. 
Disposable rocking bioreactors (RBs) are widely employed for cultivation of recombinant 
mammalian and insect cell lines, although the perception of inadequate mass transfer has 
prevented their application to bioprocesses based on microbial platforms. In an effort to 
thoroughly evaluate the suitability of disposable RBs for cultivation of aerobic microorganisms, 
a comparative study of one-dimensional (1D) and two-dimensional (2D) disposable RBs, and the 
conventional stirred tank reactor (STR) was performed. The comparison involved: 1) physical 
characterization of oxygen mass transfer efficiency and mixing intensity, 2) batch cultivation of 
Escherichia coli BL21 for comparison of growth characteristics, and 3) batch cultivation of 
recombinant E. coli BL21 expressing a clinical therapeutic, hCD83ext (the extracytoplasmic 
domain of human CD83). Oxygen mass transfer (evaluated as the mass transfer coefficient, kLa) 
was comparable between the 1D RB and STR (approximately 150 h-1) at low working volume 
(WV), declining linearly with increasing WV, while kLa was highest in the 2D RB for all tested 
WVs, providing the maximum kLa (394 h-1) at 3 L WV. Fast mixing (t95 of 8-20 s) was observed 
in all three systems for water and aqueous carboxymethylcellulose (CMC) solutions. Batch 
growth characteristics of E. coli BL21 were similar in each system, although acetate 
accumulation was significant in the 1D RB. Batch production of GST-hCD83ext (glutathione S-
transferase-hCD83ext fusion protein) resulted in similar soluble protein yields and inclusion 
body formation between bioreactors. Although cell growth and protein expression were 
comparable between all bioreactors, the 1D RB is not considered a suitable cultivation system 
for E. coli under experimental conditions given the significant acetate accumulation observed 
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and high supplemental oxygen requirement for low cell density cultures. On the other hand, 
considering its formidable mass transfer capacity and overall performance in batch cultivations, 
the CELL-tainer® is an attractive alternative to the STR for cultivation of recombinant E. coli 
expressing high value therapeutic proteins.  
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Chapter 1- Overview 
 
1.1 Research background 
Biopharmaceuticals are the fastest growing segment of the pharmaceutical industry, accounting 
for approximately one-sixth of the $600 billion global market by 2007 [1]. Due to innovations in 
recombinant protein technology over the last 10 years, the number of available therapeutics has 
dramatically increased along with product quality and titer [2, 3]. Biopharmaceuticals are 
categorized according to biological activity: blood factors (thrombolytics, anticoagulants), 
hormones, growth factors, cytokines, monoclonal antibodies (mAbs), and enzymes [4]. mAbs-
based products, accounting for 40% of total annual sales, are the most lucrative biological 
therapeutics on the market [1]. However, the rapidly increasing presence of ‘biosimilars’ is 
driving down large premiums once associated with new therapeutics [1, 5]. Additionally, high 
failure rates associated with biopharmaceuticals impart great risk to the considerable investment 
required for product development [3, 5]. The push to reduce capital investment in conjunction 
with dramatic increases in titer, pressure to reduce health care costs, preference (in some cases, 
requirement) to manufacture locally, and increased focus on multiproduct capability and niche 
markets drives the need for small, flexible, and cost effective manufacturing facilities [5, 6].  
Implementing disposable technology (i.e., bioreactors, depth filters, filtration cassettes, 
chromatography columns, piping, etc.) can address many of the concerns associated with 
biopharmaceutical process development [5-7]. Disposable components provide additional 
benefits beyond reduced initial capital investment and increased production flexibility, i.e., 
reduced occurrence of contamination (especially for multiproduct facilities) and labor costs 
associated with validation and cleaning, faster market entry due to expedited facility 
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construction, and shorter turnover times between production runs. On the other hand, disposable 
unit operations have potential drawbacks such as increased risk of failure, increased waste 
disposal costs, and additional operating costs due to regular component replacement which must 
be considered. The first widely adopted disposable bioreactor, the WAVE Bioreactor [8], was 
introduced in the late 1990s and was later acquired by GE Healthcare Life Sciences. The 
cultivation chamber is a disposable bag mounted on a rocking platform, facilitating enhanced 
surface aeration via wave propagation at the gas-liquid interface. Agitation intensity in rocking 
bioreactors (RBs) is controlled through adjustment of rocking rate (K), expressed in rocks per 
min (rpm) and vertical displacement (VD). Subsequent disposable formulations include rotary 
oscillating [9], orbitally shaken, pneumatically driven, and stirred cultivation systems [10]. 
Modern versions of these bioreactors are equipped with disposable or multiuse pH and dissolved 
oxygen (DO) probes, enabling sophisticated control schemes already employed in traditional 
stirred-tank reactors (STR).  
Initially, disposables were intended for mammalian cell culture prone to contamination 
(due to slow growth characteristics) and shear stress [11, 12]. The relatively low oxygen transfer 
required for mammalian and insect cell culture is easily achieved by disposable systems [13-16], 
although application to microbial cultivation has generally been avoided due to mass transfer 
limitations. Disposable RBs have been evaluated for cultivation of Saccharomyces cerevisiae 
[17] and Escherichia coli [18, 19] demonstrating their capability in generating low to moderate 
cell densities in batch and fed-batch mode. The latest development in disposable RBs, the two-
dimensional (2D) CELL-tainer® (CELLution Biotech), is differentiated by simultaneous rocking 
and horizontal movement, facilitating significantly higher oxygen mass transfer efficiency 
compared to one-dimensional (1D) RBs. High cell density cultivation of E. coli was achieved 
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during fed-batch operation at 12 and 120 L scales, and mass transfer efficiency (represented as 
the volumetric mass transfer coefficient, kLa) was comparable to conventional STRs [20]. 
As of 2011, approximately one-third of biopharmaceuticals having received regulatory 
approval in the United States and European Union are produced in Escherichia coli [4]. 
Demonstration of acceptable growth characteristics in disposable RBs was an important step 
towards establishing their suitability for biopharmaceutical production in microbial hosts. 
However, studies of recombinant protein expression extend only to relatively low value, 
prokaryotic proteins of no pharmaceutical interest [19, 20]. Given the considerable cost of 
disposable cultivation systems, their application is most appropriate for high value products such 
as recombinant therapeutics. Considering E. coli is the preferred recombinant host for production 
of many biopharmaceuticals, characterization of disposable RBs for eukaryotic therapeutic 
protein expression in E. coli was undertaken to provide valuable insight for future 
biopharmaceutical process development.  
 
1.2 Research objectives 
The overall objectives of this thesis were to: 
1) characterize 1D and 2D disposable RBs in terms of oxygen mass transfer efficiency (kLa) 
and mixing intensity (represented as the mixing time, tm); 
2) compare batch growth characteristics, and glucose and metabolite profiles of 
nonrecombinant E. coli in 1D and 2D disposable RBs to elucidate suitability for aerobic 
cultivation under typical conditions; and 
3) evaluate eukaryotic therapeutic protein expression in recombinant E. coli, in terms of titer 
and inclusion body formation, relative to the conventional STR. 
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1.3 Outline of thesis 
Chapter 2 is a review of economic comparison studies of stainless steel, hybrid (stainless steel 
and disposable), and fully disposable biopharmaceutical production schemes; measurements of 
oxygen mass transfer coefficients (kLa) and approaches to modelling mass transfer in bioreactors; 
measurements of mixing time (tm) and approaches to modelling mixing time in bioreactors; and 
typical cultivation conditions for recombinant E. coli and strategies to enhance recombinant 
protein expression. In Chapter 3, 1D and 2D disposable RBs are assessed and compared with 
conventional stirred tank reactor (STR) for recombinant therapeutic protein production in 
Escherichia coli. The comparison involves: 1) physical characterization of oxygen mass transfer 
efficiency and mixing intensity, 2) batch cultivation of non-recombinant BL21 for comparison of 
growth characteristics, and 3) batch cultivation of recombinant BL21 expressing a clinical 
therapeutic, hCD83ext (the extracytoplasmic domain of human CD83). Finally, Chapter 4 
summarizes the results from the investigation presented in Chapter 3 and implications to the 
biopharmaceutical industry, and proposes future studies to adequately characterize mass transfer, 
mixing, and recombinant protein production in disposable RBs. 
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Chapter 2 - Literature Review 
The considerable capital investment and high risk associated with product success and timing of 
market entry are critical factors under consideration in the planning stage of biopharmaceutical 
process development. The majority of biopharmaceutical processes are based on stainless steel 
components due to reliability and passive interaction with process media, buffers, etc. However, 
the considerable costs associated with stainless steel construction and large footprint of fixed unit 
operations ensures that even the smallest production schemes require investments well above $10 
million [3, 5-7]. For example, a small scale commercial facility operating a single 1,000 L 
stainless steel bioreactor would cost $25-40 million to construct [6, 7], while a higher capacity 
facility (≥ 10,000 L) can easily exceed $100 million [3, 6]. Additionally, novel 
biopharmaceutical life cycles are often short due to patent expiration and biosimilar introduction 
requiring jump investments every 5-10 years [1, 3, 5]. Integration of disposable components can 
significantly reduce capital investment and time-to-market, while enabling flexibility and 
increased productivity via reduced downtime. That aside, aspects such as production scale, 
expression host, and process conditions must also be carefully considered when selecting 
bioprocess unit operations. 
 
2.1 Cost effectiveness of disposable technology 
As previously discussed, disposable technology may afford key benefits for biopharmaceutical 
manufacturing in the appropriate context. Critical factors addressed early on in the development 
process are capital availability, time-to-market, and flexibility for future expansion (either for 
increased volume or additional products) [5]. Existing data indicates that significant reduction in 
capital investment is achievable by replacing stainless steel equipment with disposables, enabling 
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even distribution of capital costs over the project lifecycle. A case study of a 100 kg capacity 
mAb plant in which stainless steel and hybrid (stainless steel and disposable components) 
production platforms were compared, projected total capital cost reduction of 54% for hybrid 
versus stainless steel options [21]. This estimate is similar to that obtained in an earlier study in 
which a 42% reduction in fixed capital investment was projected for a fully disposable plant [5]. 
Variation in capital investment estimates can be significant given the dependence on Lang factor 
estimation, the ratio of total installed cost to equipment cost alone.  
Analysis of annual operating costs is a more complicated issue, particularly when 
evaluating hybrid production schemes. Relative to the conventional option, a fully disposable 
plant was projected to incur 70% greater running costs, primarily due to increased materials and 
waste disposal costs [5]. Downstream separation and purification equipment (i.e., membranes 
and chromatography columns) represented the largest expense for disposables replacement. This 
trend was observed in a subsequent cost analysis study in which the author pointed out that some 
companies use chromatography matrices in a product-specific manner, reducing the need for 
validation of performance in the absence of cross-contamination [22]. Interestingly, in this study 
operating costs were 30 and 19% lower for fully disposable and hybrid production facilities, 
respectively, compared to the stainless steel option. This is largely due to the higher number of 
projects completed annually in fully disposable and hybrid plants, owing to reduced (or absence 
of) downtime for clean-in-place/steam-in-place (CIP/SIP). This issue was not formally 
considered in the earlier study although the authors speculated that increased productivity via 
reduced turnaround time was a critical factor to address in future work [5]. Returning to the mAb 
production case study, annual operating costs were estimated to be 16% lower for the hybrid 
facility. However, certain limitations of this study must be considered: 1) disposable components 
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were mainly limited to storage bags for media, buffers, culture, etc. (disposable filters and 
membranes were employed but did not contribute significantly to cost adjustments); and 2) 
adjustments in productivity were not considered due to reduced downtime for CIP/SIP [21]. The 
first item is important as the use of disposable bioreactors, piping, ultrafiltration and diafiltration 
equipment, etc. could significantly increase waste disposal costs while, at the same time, further 
reduce utility and labor expenditures associated with CIP/SIP. The latter effect could outweigh 
the former as CIP/SIP was the greatest running expense for the stainless steel scenario [22]. In 
accordance with this study, increased productivity resulting from diminished downtime could 
further enhance cost savings estimated for the hybrid mAb production scheme.  
Another point to consider is the impact of expression host and reactor configuration, and 
inclusion of disposable chromatography matrices on yield. The preceding studies assumed equal 
yield for each scenario although sensitivity analyses indicated significant reductions in net 
present value (NPV) [5], or annual cost of goods (per gram of product) [22] for corresponding 
decrease in fermentation titer. Accordingly, selecting the appropriate bioreactor for cultivation of 
microbial expression hosts is a critical step in the development process. For example, opting for 
a disposable bioreactor to cultivate recombinant E. coli may reduce operating costs and time-to-
market while increasing annual productivity, if oxygen mass transfer is sufficient to support the 
required cell density and physiology for target protein titer. Table 2-1 presents a comparison of 
cost and performance metrics for stainless steel, hybrid, and fully disposable production 
facilities. Currently, fully disposable facilities are not necessarily a practical option, particularly 
when considering the substantial cost of disposable chromatography hardware for capturing and 
polishing therapeutics [6, 22]. Furthermore, disposable bioreactors are currently limited to 2000 
L or less such that higher production volumes will require multiple units in parallel, or 
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conventional stainless steel fermenters [6]. Consequently, the integration of disposable 
technology and biopharmaceutical development is an attractive option of increasing interest in 
industry, although factors such as expression host, production volume, and recovery costs must 
be carefully considered when deciding between disposable and stainless steel components. 
 
Table 2-1 - Comparison of cost and performance metrics between stainless steel, hybrid, and 
fully disposable production facilities [5, 21, 22]. 
Component Stainless 
steel 
Hybrid Fully 
disposable 
Fixed capital investment H M L 
Consumables/raw materials L M H 
Waste disposal L M H 
Utilities H M L 
Labor H M L 
Fermentation titer H M/H* M/H* 
Overall yield H M/H** M 
Production runs L M H 
H ≡ highest; M ≡ moderate; L ≡ lowest 
*dependent on choice of expression host and bioreactor 
**dependent on chromatography hardware 
 
2.2 Oxygen mass transfer in bioreactors 
Bioreactor selection is a critical step in the development of any commercially feasible 
bioprocess, particularly when microbial expression hosts are employed due to the high oxygen 
demand and viscous nature of fully developed cultures. The STR has been the default choice for 
cultivation of aerobic bacteria due to superior mass transfer and flexibility in terms of operating 
conditions (i.e., air flow, agitation, and pressure). The limiting factor for application of 
disposable bioreactors to microbial cultivation is assumed to be mass transfer. On the other hand, 
fed-batch operation at low growth rate along with supplemental oxygen has proven effective in 
9 
 
generating moderate to high cell densities in disposable RBs [19, 20]. Understanding the nature 
of oxygen transfer and response to fermentation parameters ensures appropriate bioreactor 
selection to achieve target yields.   
 In general, the oxygen transfer rate (OTR) is derived from the simple two film model in 
which resistance occurs across the thin film occurring on either side of the gas-liquid interface. 
Equation 1 is obtained by assuming mass transfer resistance is negligible on the gas side of the 
interface: 
𝑂𝑇𝑅 = 𝑑𝐶𝐿
𝑑𝑡
= 𝑘𝐿𝑎(𝐶∗ − 𝐶𝐿)     (1) 
where kLa, the volumetric mass transfer coefficient, is the product of the local mass transfer 
coefficient (kL) and interfacial area (a); C* is the bulk liquid saturation concentration of oxygen; 
and CL is the bulk liquid concentration of oxygen versus time (t) [23]. Mass transfer is driven by 
the concentration gradient between the interface and bulk liquid. The concentration gradient is 
affected by cellular oxygen uptake and solubility, the latter being a function of temperature, 
salinity, and pressure [24]. For the STR, spargers generate gas bubbles which are reduced in size 
(increasing interfacial area for mass transfer) and distributed by mechanically driven stirrers 
(e.g., Rushton turbine, curved blade turbine, curved blade paddle, flat blade paddle, etc.). 
Considerable effort has been made to develop empirical correlations for kLa based on parameters 
such as power input per unit volume (P/V), liquid effective viscosity (µe), and superficial gas 
velocity (Vs) [24]: 
𝑘𝐿𝑎 = 𝐴𝑉𝑠𝑎(𝑃/𝑉)𝑏𝜇𝑒𝑐      (2) 
The exponents found in Equation 2 vary significantly between studies, for example, [25-27], 
owing largely to experimental techniques used to measure kLa [27] and inherent difficulty in 
obtaining reproducible estimates. Alternatively, some correlations replace P/V with stirrer speed, 
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N [28-30], while others make use of dimensionless variables such as the Reynolds (ρNT/µe), 
Schmidt (µe/ρD), and Weber (ρN2T3/σ) numbers to evaluate kLa via the Sherwood number, 
kLaT2/D, where T is the stirrer diameter, ρ is fluid density, D is the oxygen diffusivity in liquid, 
and σ is the interfacial tension [31-33].  
A theoretical approach has also been used to determine kLa based on Higbie’s penetration 
theory [34], which estimates kL via the exposure time (te) for mass transfer represented by the 
ratio of the Kolmogorov length scale, η = (ν3/ε)0.25, and fluctuation velocity, u = (νε)0.25, of 
turbulent eddies [35] where ν is the kinematic viscosity and ε is the energy dissipation rate of 
turbulence: 
 𝑘𝐿 = 2� 𝐷𝜋𝑡𝑒 = 2 �𝐷𝜋�1 2� �𝜀𝜈�1 4�     (3) 
A theoretical basis for kLa determination is attractive due to inconsistency between empirical 
correlations obtained under similar conditions, and the simplified manner in which dependencies 
on reactor geometrical parameters are lumped together (i.e., constant A in Equation 2). 
Theoretical models will provide a better understanding of the relationships between process 
parameters and kLa, reducing the difficulty inherent to bioreactor scale-up, a complicated process 
which is highly dependent on maintaining acceptable mass transfer. For example, referring to 
Equation 2, dependence on Vs varies widely (0.3≤ a ≤0.7) although an increase in kLa with air 
flow rate is anticipated (over the range of conditions tested). On the other hand, ε and, in turn, kL 
have an inverse dependence on Vs (aeration reduces power consumption relative to non-aerated 
systems), while interfacial area (a) increases with Vs [34]. Sensitivity analyses and optimization 
could enhance bioreactor performance and process efficiency, particularly when interactions 
between Vs and N are considered. Qualitatively, kLa is controlled by mechanical agitation for 
N>Nc (agitation controlled), where Nc is the critical impeller speed, negating the impact of 
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aeration [29, 36]. Similarly, under vigorous aeration and N<Nc, agitation has a negligible effect 
on kLa (bubbling controlled) [29]. A previous study demonstrated that constants associated with 
Vs and N in standard correlations vary significantly across the intermediate regime. [29]. 
Consequently, operation in the intermediate regime (the most common situation) would be most 
efficient under optimized conditions based on consideration of expression host, sensitivity of 
product to oxidation, relative utility and process gas costs, etc. Obviously, this approach could be 
extended to disposable bioreactors as models become available. kLa values from select studies 
are presented in Table 2-2. 
 
Table 2-2 - kLa data from selected studies of STRs 
Reference Vs x103 
(m/s) 
P/V x10-3 
(W/m3) 
N (s-1) DT 
(m) 
T  
(m) 
V 
(L) 
Liquid µe 
(mPa·s) 
kLa  
(h-1) 
[25] 6.3 0.6-4.8 4.2-8.3 0.9 0.27 600 water 1.0 170-1613 
 12.7 0.4-3.7       218-1228 
[27] 5.0 1.0-6.0 --- --- --- 9 water 1.0 125-220 
 14.0 0.5-6.0       150-360 
[29] 4.2 --- 1.7-
16.7 
0.15 0.05 2.7 water 1.0 23-250 
 11.3        60-360 
 0.9-
11.3 
 5.0      13-65 
   13.3      100-200 
[32] 3.8 --- 5-10 0.25 0.1 12.3 glycerol
-water 
9.1 70-230 
 2.0-8.0  6.7      100-150 
 3.8  5.0-
10.0 
   CMC 
(0.4 %) 
--- 15-180 
[28] 0.6-2.1 --- 5.0 0.12 0.05 2 xanthan  
gum 
2.7 13-18 
 2.1  5.0-6.7      20-30 
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As previously discussed, oxygen transfer in disposable RBs occurs through surface 
aeration via wave propagation at the gas-liquid interface. Although empirical correlations 
relating kLa to rocking rate, K (expressed as rocks/min, rpm), VD, working volume (WV), air 
flow rate, and P/V have not been formulated, general trends have been established for 1D and 2D 
RBs. During the introduction of the 1D RB, kLa was reported to depend weakly on K at low air 
flow rate (≤ 0.05 vvm), while increasing significantly with rpm at 0.1 vvm [8]. The kLa increased 
moderately from 0.01 to 0.04 vvm, but increased dramatically from 0.04 to 0.1 vvm (2.7-fold). In 
another study of a modified GE Wave bioreactor fitted with a frit sparger, kLa increased 
marginally with K without headspace aeration, although for agitation below 25 rpm the effect of 
headspace aeration was less significant [17]. Similarly, increasing the gas flow rate from 0.25 to 
0.5 vvm corresponded to a small increase in kLa (14%) at moderate rocking speeds [37]. 
Accordingly, the low gas flow capacity of 1D systems is not a limiting factor during cultivation 
of mammalian, plant, and insect cells at low to moderate K. However, increased gas flow 
capacity may provide significant improvements in oxygen transfer at high agitation, bolstering 
the potential of 1D RBs for aerobic microbial fermentation. As anticipated, kLa increased with 
VD, although K and VD were relatively low as mAB production in a myeloma/mouse hybridoma 
cell line was under investigation [38].  
Similar trends in kLa were observed for K and VD in the CELL-tainer® compared to 
Wave bioreactor. kLa increased with K up to 35 rpm (maximum rpm tested) for 5, 10, and 15 L 
WV (20 L cultivation bag), exceeding values of 500 h-1 [20], and no significant increase in kLa 
was observed beyond 40 rpm for 15 L WV except under maximum VD [39].  Two key 
advantages of the CELL-tainer® relative to 1D RBs are the capacity to 1) process up to 75% of 
total bag volume (compared to 50% in 1D RB) while maintaining formidable kLa, and 2) handle 
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significantly higher gas flow rates, although kLa is not dependent on air flow rate [39]. Due to the 
complex nature of fluid flow in the CELL-tainer®, optimization of VD and K for a given WV 
may be prudent. During 10-fold scale-up of the CELL-tainer®, kLa maxima were observed for 
different combinations of rpm and WV [20]. It follows that selecting extremes of K for any WV 
may inhibit the kLa, while maximizing energy consumption. 
To better understand the dynamics of fluid flow in RBs, one must consider the nature of 
wave development in shallow water. 
 
Figure 2-1 - General characteristics of a wave [40] 
 
Referring to Figure 2-1, a wave of period τ, height H, and length L initially travels at speed C = 
L/τ. As the wave travels into shore, the water depth beneath it (h) decreases, until the wave 
reaches shallow water based on the criterion, h/L ≈ 1/20 [40]. In shallow water, wave speed is 
described by Equation 4: 
𝐶 = �𝑔(ℎ −𝑚𝑥)      (4) 
where x is positive in the direction of the shore and m is the slope of the shore [41]. H is 
inversely proportional to C, and as the wave slows down (i.e. as h decreases), H begins to 
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increase (a process known as shoaling) until the critical height is achieved. At this point, wave 
breakage occurs dissipating energy in the form of turbulence. The water depth at which breakage 
occurs (hb) is approximated by Equation 5 [40]: 
ℎ𝑏 = 1
𝑔
1
5� 𝜅
4
5�
�
𝐻0
2𝐶0𝑐𝑜𝑠𝜃0
2
�
2
5�
     (5) 
where κ is a constant dependent on the slope of the shore (m), θ is the angle of incidence of the 
wave, and the zero subscript denotes properties in deep water. The breaking height (Hb) is 
simply, Hb = κhb  [40]. In general, H0 and C0 increase with τ [42], C and κ decrease with 
increasing m [40, 41], and τ depends on the total energy of the wave [42]. In the context of a 
disposable RB, C and κ decrease with increasing VD, and τ depends upon P/V which is dictated 
by WV, K, and VD. The bag geometry is fixed, and as a result, H cannot exceed an upper limit. 
Due to the increase in h across the length of the cultivation bag, and, in part, a restriction on H, C 
will tend to decrease more gradually as WV increases. Consequently, as WV increases the wave 
travels farther across the bag before breaking, approaching the end of the bag opposite inception 
for large WV. Delayed breaking of the wave reduces the extent of turbulent air entrainment, in 
turn, reducing mass transfer (and the kLa). This logic favors smaller WV to obtain the maximum 
kLa. A final point to consider is the total wave energy (per unit width), E, taken as the sum of a 
wave’s potential and kinetic energies as per Equation 6 [40]: 
𝐸 = 1
8
𝜌𝑔𝐻2𝐿                    (6) 
E could be used to estimate ε for a breaking wave which, in turn, could be used to determine kL 
via Equation 3. This approach could be used in subsequent studies to obtain theoretical models of 
mass transfer in disposable RBs in the same way it has been applied to STRs [34]. Note that 
Equation 6 provides only an approximation of E as its derivation assumes the wave to be a non-
dissipative system, and is based on linear wave theory which is most accurate in water of 
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intermediate depth [40].  In any case, it is clear that deeper investigation is required to elucidate 
the effects of operational parameters on mass transfer in RBs. While empirical correlations 
describing kLa would be a step in the right direction, the development of theoretical models or 
application of advanced computational methods (i.e. computational fluid dynamics, CFD) will 
greatly enhance process optimization and scale-up. Table 2-3 contains kLa values for disposable 
RBs obtained under different operating conditions. 
 
Table 2-3 - kLa data from studies of disposable RBs 
Reference Type Flow rate 
(vvm) 
VD 
(°) 
Rocking 
rate (rpm) 
WV(L) Bag 
volume (L) 
Liquid kLa (h-1) 
[8] 1D 0.01 --- 5-30 10 20 Water 0.6 
  0.04      0.5-1.5 
  0.10      0.7-4.0 
[17] 1D 0.10 10 40 5 10 PBS, 
antifoam 
38.0 
       PBS 68.0 
[38] 1D 0.05 4.5 8-13 2 10 --- 1.6-3.0 
   6 8    3.2 
   5 8-10 3.5   2.3 
[20] 2D --- --- 35 5-15 20 --- 50-500 
[39] 2D --- 8 24-48 15 20 water 40-200 
   12 30-48    120-240 
    24-48    60-295 
 
 
2.3 Mixing intensity in bioreactors 
The quality of bulk mixing in STRs can be expressed in terms of the axial dispersion coefficient 
(Ez), or the mixing time (tm). [43]. Ez is an important design characteristic describing the extent of 
mixing, although tm, representing the time required to reach a specified degree of homogeneity 
after pulse introduction, is considered more relevant in the field of biotechnology [44]. The 
distribution of substrate (i.e. oxygen, glucose, etc.), metabolites (i.e., lactate, acetate, ethanol, 
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etc.), and acid and base for pH control can significantly impact culture performance [45, 46]. 
Accordingly, in combination with kLa, tm is a critical parameter used in the scale-up of industrial 
fermenters. As in the determination of kLa, Kolmogorov’s theory of isotropic turbulence has been 
applied to models describing Ez in STRs [43, 44]. A relationship between Ez and tm was 
established leading to the conclusion that, in the turbulent flow regime, the dimensionless mixing 
time (tmN) is essentially constant for fixed reactor configurations [44], substantiating the results 
of previous studies [47]. However, relatively simple theoretical models of this nature do not 
adequately address the influence of aeration on tm, as only an indirect dependence of ε on gas 
flow rate exists (as previously discussed in Section 2.3).  
Empirical correlations have been developed for dimensionless mixing time in single stage 
(i.e. single agitator) unaerated systems, and for aerated systems operating above and below Nc 
[36]. In each case, agreement with experimental data was within 20-25%. More recently, the use 
of multi-impeller STRs of reduced diameter/height (DT/HT) ratios has become common practice, 
reducing the footprint of larger fermenters. Multi-stage agitation requires new approaches to 
hydrodynamic characterization given the increased complexity of fluid and gas dispersion. 
Currently, the Compartment Model Approach (CMA), an effective tool demonstrated in earlier 
studies of bioreactor scale-up [48, 49], is commonly used to evaluate mixing time in multi-stage 
STRs [50-55]. Studies in which CMA is applied vary in the assignment of reactor compartments. 
The simplest configuration consists of a single compartment per agitator stage [51, 52], where 
each compartment is treated as an ideally mixed vessel in series as per Equation 7: 
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Figure 2-2 - Schematic representation of single compartment (per stage) model for STR with 
three agitators (stages). 
 
where Vk is the volume of compartment k; Ck is the tracer concentration in compartment k; and 
the exchange flow rate (QE) between compartments is the unknown parameter obtained through 
regression analysis [51, 52]. Although single compartment/stage models were considered 
adequate (as long as agitator spacing is ≥ DT), increasing the number of compartments (up to 
four/stage) improved model accuracy in another study of an unaerated system [50]. Additionally, 
other investigators have employed as many as 15 compartments per stage, plus an additional 10 
compartments for the secondary circulation loop (induced by aeration) in the reactor top, for 
axisymmetric STR modelling. Sensitivity analysis indicated this configuration to be suitable for 
modeling overshoot response curves, and model estimates of tm were in good agreement with 
experimental data (±5-15%) [54, 55]. As expected, more sophisticated models require estimation 
of an increasing number of flow parameters, e.g. the division of exchange flow to components of 
QE 
QE QE 
QE 
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circulation flow (QCF) due to mechanical power, axial turbulent exchange (QTE), and gas induced 
flow (QGI) resulting from density gradients due to gas hold-up [54].  
As previously discussed, the accuracy of empirical models is often unsatisfactory for 
moderate variations in operating conditions and reactor configurations. While CMA is a useful 
tool for bioreactor design, it suffers from reliance on regression analysis of empirical correlations 
to obtain flow parameter estimates. A fundamental approach to reactor characterization is 
computational fluid dynamics (CFD), an advanced technique recently applied to modelling of 
aerated STRs [56-58] and disposable RBs [59]. CFD relies on the numerical solution of 
continuity equations for mass, momentum, and energy to simulate multi-phase flow systems 
[56]. In a recent CFD simulation of a single-stage aerated STR, excellent agreement was 
observed between experimental and predicted tm (±5-10%) [58], demonstrating the utility of the 
theoretical approach to bioreactor modelling. It is anticipated that CFD will be the dominant 
method of bioreactor scale-up in the years to come. 
A reduction in tm with increasing N is intuitive and has been well established [36, 51, 55]. 
A pronounced effect on tm was observed between impeller types in the absence of aeration. Axial 
flow impellers (Scaba type) were found to reduce tm by half compared to Rushton impellers 
(radial flow) for the same specific power consumption [55], which was attributed to reduced 
zoning in the flow field of the axial impeller facilitating enhanced circulation and QE. When 
aeration is present, two opposing effects dictate power distribution in STRs: 1) reduced 
mechanical power from the agitator(s) due to gas hold-up (ρ declines), and 2) induced axial flow 
from rising air bubbles [53]. Earlier work demonstrated that below Nc, an increase in Vs reduces 
tm to a point at which it levels off as flow rate increases [36]. For operation near Nc, tm initially 
increases upon aeration, however, further increase in Vs reduces tm until it eventually stabilizes. 
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Similar trends were observed in a later study in which drastic reductions in tm were observed 
during aerated operation at low N (<150 rpm), relative to no aeration, after which tm increased 
gradually with N approaching the unaerated condition [51]. The decrease in tm at high Vs in the 
critical agitation region observed in the former study was most likely due to impeller flooding. A 
slight increase in tm with aeration rate was observed prior to a sharp drop as flooding commenced 
[54]. Table 2-4 contains selected tm values for STRs obtained under different operating 
conditions. 
 
Table 2-4 - tm data from selected studies of STRs 
Reference Vs x103 
(m/s) 
N (s-1) DT 
(m) 
T  
(m) 
V 
(L) 
Liquid Agitator 
type 
t95  
(s) 
[36] 0-30 5 0.3 0.10 21.2 Water FBDT 10.3-4.0 
  10.6      5.5-7.5 
  6.4     PBT 10.3-7.8 
  14.3      5.0-6.5 
[51] 0 2-6 0.29 0.1 76.6 Water RT x 4 195-70 
 3.8       30-75 
 10.1 0-6      15-75 
 0 2-6     PBT x 4 235-80 
 3.8       20-70 
 10.1 0-6      15-40 
[60] 3.7 5-10 0.24 0.08 10.9 Water RT 16-8 
 0-7.4 6.7      10-13 
  8.3      8-9.5 
[53] 0-8.7 2.7 0.29 0.146 58.7 Water RT x 3 82-12 
  5.0      43-48 
  10.0      21-28 
FBDT: flat bladed disc turbine 
PBT: pitched blade turbine 
RT: Rushton turbine 
 
 
 As is the case for mass transfer studies, investigations of mixing characteristics in 
disposable RBs are limited in number. Upon introduction of the Wave Bioreactor, tm of 5-10 s 
was reported for 20 L cultivations bags (10 L WV), while 200 L bags (100 L WV) could achieve 
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homogeneity in 60 s [8]. However, operating conditions (i.e. K and VD) were not fully specified 
providing only a rough estimate of expected performance. More detailed analysis of mixing in 
1D RBs was performed in a later study of the GE Wave bioreactor [37]. A modified Reynolds 
number (Remod,1D) was derived by implementing correction factors B, accounting for the effects 
of bag geometry and VD on the volumetric flow rate (Q) of fluid, and F, relating Remod,1D to the 
modified Reynolds number obtained for stirred reactors (Remod,str): 
𝑅𝑒𝑚𝑜𝑑,1𝐷 = 𝑄𝐾𝐵𝐹15𝜐(2𝑦+𝑊)     (8) 
where y is the liquid level in the bag and W is the bag width. The critical value of Remod,1D, i.e. 
for which turbulent flow ensues, was found to vary significantly with cultivation bag size, 
ranging from 400 to 1000. Application of moderate to high K (≥18 rpm) and VD (≥6°) was 
sufficient to ensure operation in the turbulent flow regime. Accordingly, tm was independent of 
WV during operation under the specified conditions in an analogous manner to the STR, for 
which dimensionless mixing time was constant (with increasing Remod,str) in the turbulent flow 
regime for a particular reactor configuration. These findings indicate that adequate mixing 
intensity is achievable for moderate P/V; however, mass transfer remains the limiting factor for 
cultures of high oxygen demand. As anticipated, tm was a strong function of K and VD [37]. 
 Mixing characteristics were thoroughly evaluated in both the BIOSTAT® Cultibag RM 
(1D RB)  and CELL-tainer® via response surface modelling of tm as a function of K, VD, and 
WV [61]. Equations 9 and 10 were proposed for the BIOSTAT® Cultibag RM and CELL-
tainer®, respectively: 
𝑡𝑚 = −125.82𝐾 − 42.89𝑉𝐷 + 135.65𝐾2 + 42.08𝐾 ∙ 𝑉𝐷     (9) 
𝑡𝑚 = −0.308𝐾 − 0.345𝑉𝐷 + 0.179𝑊𝑉 + 0.219𝑉𝐷2 − 0.112𝐾 ∙VD (10) 
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Adherent Vero cells were cultivated in the 1D RB first to establish conditions (corresponding to 
measured tm) for which microcarrier suspension and homogeneity were acceptable. Process 
transfer to the CELL-tainer® was achieved using Equation 10 to establish K and VD (for 3 L 
WV) corresponding to tm established in the 1D system. This approach was successful as cell 
density, microcarrier distribution, metabolite profiles, and virus production were comparable 
between 1D and 2D RBs. As in the previous study, WV did not significantly impact tm in the 1D 
RB, as per the proposed model (Equation 9), although this parameter was included in the model 
for the CELL-tainer® (Equation 10). However, the full range of K was not tested in the latter 
case such that the CELL-tainer® may not have been operating in the fully turbulent flow regime. 
In a previously mentioned study, tm estimation was conducted in both 20 and 200 L cultivation 
bags for different WV [20]. As in the previous study, tm decreased with increasing K and a minor 
dependence on WV appeared to exist, although the latter observation is inconclusive based on 
the negligible difference observed between many of the data points and lack of available 
standard errors. The authors pointed out that the modified Reynolds number derived for the 1D 
RB (Remod,1D) may not be adequate in describing the hydrodynamics of the CELL-tainer® as the 
fluid is completely passing the point of rotation due to horizontal platform movement. In any 
case, further investigation of wave propagation, velocity distribution, and shear rates via 
advanced modelling techniques such as CFD would greatly improve our understanding of the 
complex hydrodynamics in 2D RBs. CFD has been successfully employed for this purpose in 1D 
RBs [59], and is proving to be an indispensable tool for bioreactor scale-up. Table 2-5 contains 
tm data for disposable RBs: 
 
22 
 
Table 2-5 - tm data for disposable RBs 
Reference Type VD 
(°) 
Rocking 
rate (rpm) 
WV 
(L) 
Bag volume 
(L) 
Liquid t95  
(s) 
[37] 1D 5 6-24 80 200 water 540-120 
    100   880-120 
  8 6-20 80   320-90 
    100   390-90 
  10  80   200-70 
    100   240-70 
[61] 1D 4 6-30 1 2 PBS 300-30* 
  8 10, 16    200, 95* 
 2D 8.5 15 5 20  65* 
  17 5, 25    125, 20* 
  8.5 5-25 10   200-50* 
  17 15    70* 
  8.5 15 15   150* 
  17 5, 25    270, 45* 
[20] 2D --- 15-35 5 20 water 15-9 
    10   16-14 
    15   20-14 
   8-30 75 200  138-100 
    115   140-66 
   15, 30 150   114, 84 
*t85 
 
 
2.4 Cultivation of E. coli for recombinant protein expression  
E. coli is the organism of choice for industrial recombinant protein production due to 1) its 
superior growth characteristics in inexpensive media, 2) high productivity, 3) the extensive 
knowledge of its physiology, and 4) the availability of advanced techniques for genetic 
manipulation [4, 62, 63]. Obtaining high level protein expression in E. coli is a challenging 
endeavor, one that demands compromise between cell growth and functional protein expression. 
On the one hand, cell densities exceeding 200 g/L dry cell weight (DCW) have been obtained 
during dialysis fermentation of E. coli [64], while on the other, high level expression can result 
in yields of up to 50% of total cellular protein via strong promoters [65]. Cultivation conditions 
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facilitating optimal growth rarely favor high functional protein yields [63] such that process 
optimization is required to identify satisfactory conditions for both. 
 Process development for recombinant protein expression in E. coli requires optimization 
of media components, temperature, oxygen saturation, agitation, and induction conditions. Media 
tailoring is an essential step in bioprocess development as an appropriate formulation facilitates 
control of growth rate (µ), cell density, and metabolite formation [62, 66, 67], protein folding 
and solubility [68], and downstream purification of recombinant proteins [69]. Defined media 
containing essential nutrients such as ammonium, phosphorus, zinc, iron, and magnesium can 
significantly improve biomass yields relative to complex media (i.e. lysogeny broth) [62], while 
glucose limiting feeding strategies are used to moderate growth rate, in turn, reducing respiration 
and metabolite formation [62, 70]. Inclusion of the trace elements selenium, nickel, and 
molybdenum was shown to reduce formate accumulation in oxygen limited fed-batch cultures of 
strain W3110 through activation of the formate hydrogenylase (FHL) complex [67]. 
Additionally, higher growth rates were achievable prior to the onset of significant acetate 
accumulation in glucose-mineral salts media as compared to complex media (0.35 versus 0.2 h-
1), and the maximum specific acetate production rate was two-fold greater in complex media 
[71]. Inhibitory acetate levels seem to vary significantly between strains and in the presence of 
different carbon sources. One study of strain K12 found acetate to be growth inhibiting at 
concentrations as low as 0.5 g/L in glucose minimal media, while growth inhibition occurred 
above 1 g/L with glycerol as sole carbon source [72]. On the other hand, growth inhibition of 
recombinant MC1061 (K12 derivative) expressing human growth hormone (hGH) was observed 
once acetate reached 6 g/L in semi-defined glucose media [73]. Specific hGH production 
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decreased when acetate exceeded 2.4 g/L. As a general rule of thumb, however, acetate should 
be maintained below 2 g/L to avoid inhibition of growth and protein expression [62].  
  Cultivation of E. coli for recombinant protein expression is often conducted at 
suboptimal growth temperatures to facilitate protein folding [68], reduce proteolytic degradation 
[74], and enhance chaperone activity [75]. Penicillin acylase (PGA), a common industrial 
enzyme used in the production of semisynthetic penicillins and cephalosporins, is produced via 
fermentation of recombinant E. coli at temperatures of 25-30 °C to enhance translation and 
enable proper folding [76]. Particularly low optimal temperature (21°C) has been reported for 
functional expression of the κ-chain and Fd fragment of an antigen-binding fragment (Fab) 
possessing antibody activity against carcinoembryonic antigen [77]. While the growth rate of    
E. coli is significantly diminished at temperatures below 30 °C, expression of heterologous 
chaperones originating from a psychrophilic organism (Oleispira Antarctica) was shown to 
significantly increase growth rate at low temperature (< 15°C) [75]. Tailoring the temperature 
dependency of growth rate based on optimal protein expression conditions could be an attractive 
genetic strategy in the future.  
 Critical DO in E. coli fermentations, based on the criterion µ = 0.97µmax, was reported as 
relatively low (0.12 mg/L) [78], although in practice DO is maintained well above critical levels 
to minimize metabolite formation [64, 79]. DO is controlled through a cascade of agitation rate 
and gas flow composition (oxygen/air) and volume, and has been used as feed indicator in fed-
batch cultivations [80]. Mass transfer in high cell density (HCD) cultures is a limiting factor due 
to the poor solubility of oxygen in aqueous media and high oxygen demand of fully developed 
cultures. Fed-batch strategies in which the carbon source remains low to reduce oxygen 
requirement are commonly employed to offset inadequate oxygen transfer [81]. While average 
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oxygen levels in a bioreactor are typically not excessive, local concentrations can be markedly 
elevated in oxygen-enriched cultures, particularly in the vicinity of the sparger(s) [82]. Oxidative 
stress from exposure to reactive oxygen species (ROS) such as H2O2, O2-, and OH∙ can result in 
DNA instability, and protein and lipid denaturation [83]. Previous studies have demonstrated that 
the effects of excess DO on the growth of E. coli are strain dependent. Marginal reductions in the 
growth rates of strains TB-1 [84], W3110 [85], and MG1655 [86] were observed in oxygen-
enriched culture, while the growth rate of JM101 declined significantly [84]. Moreover, excess 
DO can reduce the yields of certain recombinant proteins via oxidation of Met and Cys residues 
[83], resulting in misfolding, loss of activity, and protease degradation [87, 88]. Reduced yields 
have been observed for recombinant hGH [85], p24Gag (human immunodeficiency virus-1 
protein) [89], and monoamine oxidase (MAO) [90] in oxygen-enriched E. coli fermentations. 
 Selection of induction conditions (i.e. inducer concentration and induction timing) 
depends on the structure of recombinant DNA, expression host, and type of desired product. For 
inducible expression systems, e.g. those derived from the lac operon of E. coli, promoter 
strength, translational efficiency, and posttranslational processing capacity dictate optimal 
inducer concentration [91, 92]. Plasmid copy number is usually complementary to promoter 
strength [91], although copy number can be manipulated to tailor gene dosage [93]. A strong 
promoter is most beneficial when structural components such as ribosome binding site (RBS), 
start codon, and spacer between RBS and start codon are optimized [94] reducing bottlenecks 
associated with translation. Strong promoters coupled with excessive inducer levels may cause 
severe insoluble protein aggregation (inclusion bodies) resulting in reduced soluble protein 
production and cell lysis [92]. Moreover, optimal inducer concentrations vary widely for 
different expression systems (i.e. strain-vector-promoter combinations) intended for the same 
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protein, such that inducer optimization is required upon modification of expression vector or 
strain. For example, in strain JM109, specific PGA activity was highest upon induction of the trc 
promoter with 0.05 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), while specific activity 
peaked at 0.2 mM IPTG for T7 driven expression (peak specific activity was within 7%) [95]. 
Differences in posttranslational processing efficiency (i.e. translocation, proteolysis, and folding) 
between strains also influences extent of induction [92], although coexpression of cytoplasmic 
chaperones may improve posttranslational maturation, in turn, reducing inclusion body formation 
[96]. In general, for lac derived promoters, it is generally accepted that IPTG need not exceed 1 
mM for full induction of protein expression [97]. Induction timing depends on the type of 
recombinant protein expressed (i.e. growth, mixed-growth, or non-growth associated) [76, 98] 
and the extent of growth arrest upon induction [97]. Induction during exponential phase (i.e. at 
high growth rate) is optimal  for expression of growth-associated proteins [98], although for 
mixed-growth associated products induction could be delayed until early stationary phase, 
potentially improving yields via increased biomass accumulation during uninduced exponential 
growth [76]. Accordingly, induction during early stationary phase at maximum cell density is 
ideal for non-growth associated protein production.  
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3.1 Introduction 
Due to the highly competitive nature of today’s biopharmaceutical market and the high failure 
rates associated with biopharmaceuticals [5], flexible and cost-effective manufacturing facilities 
are prerequisite for survival of biopharmaceutical producers. Over the last decade, disposable 
bioreactors have become integral components in the production of many high-value 
biopharmaceuticals [6]. Advantages of disposable bioreactors compared to conventional tank 
reactors include high flexibility, reduced occurrence of cross-contamination, lower capital 
investment, reduced labor costs associated with validation and cleaning, and shorter turnover 
times between production runs [5, 10]. Disposable bioreactors are classified by mode of power 
input as mechanically driven (wave-mixed, stirred, orbitally shaken or vertically oscillating), 
pneumatically driven, or hybrid systems [10].  
Wave-mixed RBs were introduced in the late 1990s [8], and are commonly employed in 
the production of biopharmaceutical products (e.g. monoclonal antibodies, vaccines, therapeutic 
and diagnostic proteins, etc.) in mammalian [13, 15], plant [99], insect [16], and human cell 
cultures [100]. These cultivation systems typically consist of an oscillating or sectional platform, 
supporting one or more pre-sterilized cultivation bags made of biologically inert polymers such 
as polyethylene, polypropylene, or polytetrafluoroethylene. Temperature is controlled through 
the moving platform or external cabinet. Bags are equipped with disposable or multiuse online 
pH and DO sensors. Gas-liquid mass transfer occurs through surface aeration and turbulent air 
entrainment via wave propagation and is controlled by adjustment of VD and rocking rate. While 
reports of cultivation of microorganisms in disposable RBs [17-20] exist, it is commonly 
assumed that these disposable systems are not capable of meeting the high oxygen demand of 
microbial cultures. Towards the end of 2011, 66 out of 211 biopharmaceuticals receiving 
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regulatory approval in the United States and European Union are produced in Escherichia coli 
while mammalian cells represent the most common host system for biopharmaceutical 
production [1]. However, few reports exist on the application of disposable RBs to recombinant 
therapeutic protein production in E. coli.  
The oscillation trajectory for most RB platforms is 1D, limiting the extent of wave 
development and, in turn, the efficiency of mass transfer. The CELL-tainer®, a RB with an 
innovative design of 2D oscillation trajectory, moves around the axis of rotation in a closed loop 
facilitating simultaneous vertical and horizontal displacement [61]. 1D systems tilt along a 
central pivot axis which only a portion of the fluid is able to pass with each oscillation [59]. In 
the CELL-tainer®, the fluid completely passes the center of the bag due to the additional 
horizontal movement, which may partially explain increased mass transfer due to additional film 
formation along the bottom of the bag [20]. Additionally, the CELL-tainer® provides more 
efficient mass transfer with respect to specific power input, and is capable of processing larger 
WVs and higher gas flow rates compared to 1D RBs [39]. Previous studies of oxygen transfer 
efficiency in 1D RBs report kLa values in range of 38 to 55 h-1 [17, 19], while kLa exceeded 500 
h-1 in the CELL-tainer® at maximum WV [20]. In this study, the CELL-tainer® was used for 
recombinant therapeutic protein production in E. coli and the culture performance was compared 
with the traditional stirred-tank reactor (STR) and 1D RB. The target protein of GST-hCD83ext 
is a protein fusion of glutathione S-transferase and the extracytoplasmic domain of human CD83 
(hCD83ext), and the bioprocess for its expression and purification was previously developed 
[63]. We specifically investigated oxygen transfer efficiency and mixing intensity of 1D and 2D 
disposable RBs to evaluate performance relative to the STR. RBs are believed to provide an 
environment suitable for shear-sensitive and fragile microbial recombinant cells. Batch growth 
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characteristics, glucose consumption, and metabolite profiles of non-recombinant E. coli were 
compared to elucidate suitability of RBs for cultivation under typical culture conditions. Also, 
culture performance for recombinant GST-hCD83ext expression was evaluated under previously 
optimized culture conditions, and soluble and insoluble fractions of cell lysates were analyzed to 
assess titer and inclusion body formation.  
 
3.2 Materials and methods 
3.2.1 Physical characterization and OUR estimation 
10 L and 20 L cultivation bags were used for physical characterization and cultivation in the 1D 
and 2D (CELL-tainer®, CELLution Biotech, The Netherlands) disposable RBs, respectively. 
Different WVs were tested under conditions providing maximum oxygen transfer, i.e. 40 rpm 
and 12° VD (1D RB), and 40 rpm and 17° VD (CELL-tainer®). Trials were conducted at 28 °C 
and 0.4 vessel volume per minute (vvm) aeration rate. Measurements of kLa were performed 
using the dynamic “gas out-gas in” method [101]. The cultivation chamber was filled with an 
appropriate volume of deionized water, which was subsequently stripped of oxygen by nitrogen 
purging until the DO level fell below 5% of air saturation. The headspace was evacuated with a 
vacuum pump (GAST, Michigan, USA) and then filled with air. Once the headspace was full, 
agitation resumed and DO measurements were recorded at appropriate time intervals.  An optical 
DO sensor was used without the oxygen permeable membrane resulting in a time constant of < 6 
s.  kLa estimates were obtained from the mass balance equation: 
𝑙𝑛 �
𝐷𝑂∗−𝐷𝑂(𝑡)
𝐷𝑂∗−𝐷𝑂(𝑡0)� = −𝑘𝐿𝑎(𝑡 − 𝑡0)     (11) 
where DO* is the saturation reading of the probe.  The volumetric oxygen uptake rate (OUR) was 
measured during exponential growth by temporarily stopping the supply of gas to the cultivation 
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chamber, evacuating the headspace, and recording DO measurements upon resuming platform 
movement.  The following mass balance equation was used to estimate the volumetric OUR: 
𝐶𝑂2,𝑙(𝑡0)− 𝐶𝑂2,𝑙(𝑡) = 𝑂𝑈𝑅(𝑡 − 𝑡0)     (12) 
where 𝐶𝑂2,𝑙 is oxygen concentration in the liquid phase (approximated using solubility data and 
DO measurements). tm was evaluated by adding an acidic tracer (HCl) to the system at a steady-
state pH, and estimating the time required to achieve 95% of the pH set-point change (t95). 
Experimental conditions were identical for kLa and tm estimation. kLa, OUR, and tm 
measurements in the 1 L STR (Omni-Culture, VirTis, NY, USA) were performed similarly, 
except that headspace evacuation and filling was not required, enabling continuous operation. 
For the STR, tank diameter = 10 cm, stirrer diameter = 5 cm (2 × 6 flat blade paddle), liquid 
height = 12 cm, and agitation was maintained at 600 revolutions per minute (rpm). All other 
conditions were maintained the same as those of the disposable RBs. 
 
3.2.2 Bacterial strains and plasmids 
E. coli BL21 (F- ompT gal [dcm] [lon] hsdSB (rB- mB-) λ(DE3)) was used to investigate growth 
characteristics.  Plasmid pGEX2ThCD83ext containing hCD83ext cDNA fused to the gst gene, 
served as expression vector for production of recombinant GST-hCD83ext under control of the 
strong tac promoter. BL21 containing plasmid pLysS harboring the gene encoding T7 lysozyme 
was used as the expression host to minimize leaky expression [102]. 
 
3.2.3 Cultivation 
Cells were maintained as glycerol stocks at -80 °C and revived on LB agar plates (10 g/L NaCl, 
5 g/L Bacto yeast extract, 10 g/L Bacto Tryptone, 15 g/L Bacto Agar) supplemented with 
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ampicillin (50 mg/L) and chloramphenicol (17 mg/L) as needed. Selected colonies were 
transferred to LB shake-flasks and grown for 16 h at 225 rpm and 37 °C in an orbital shaker 
(New Brunswick Scientific, New Jersey, USA) to generate the seed culture. E. coli BL21 was 
cultivated in LB broth supplemented with 20 g/L glucose and 15 µL/L Antifoam 204 (Sigma 
Aldrich). Cultivations were performed at 30 °C, 0.4 vvm  aeration rate, 40 vol% O2, 40 rpm and 
12° VD (1D RB), 40 rpm and 17° VD (CELL-tainer®), and 600 rpm (STR). pH was maintained 
at 6.8 ± 0.1. Recombinant BL21(pGEX2ThCD83ext, pLysS) was cultivated in modified LB 
broth (5 g/L NaCl, 20 g/L Bacto yeast extract, 20 g/L Bacto tryptone) supplemented with 5 g/L 
glucose, 15 µL/L Antifoam 204, and 50 mg/L ampicillin. The same cultivation conditions were 
used as for non-recombinant BL21 except for small variations in temperature (28 °C) and pH (7 
± 0.1). When the cell density reached 1.5-1.8 OD600, isopropyl β-D-thiogalactopyranoside 
(IPTG) was added to 0.5 mM for induction of protein expression.   
 
3.2.4 Sample preparation and analysis 
To obtain cell extract, cells in the amount of 30 OD600-units (defined as the product of OD600 and 
sample volume in mL) were centrifuged at 8,000g and 2 °C for 10 min. The supernatant was 
collected and filter sterilized for analysis of glucose and metabolites using a Shimadzu LC-10AT 
HPLC with RID-10A refractive index detector (Shimadzu, Kyoto, Japan) and Aminex HPX-87H 
column (Bio-Rad Laboratories, CA, USA). The cell pellet was resuspended in 1.5 mL 
phosphate-buffered saline (PBS) and sonicated intermittently (0.5/0.5 s on/off) for 2 min with an 
ultrasonic liquid processor and microtip (Sonicator 3000, Misonix, NY, USA). The lysate was 
centrifuged at 18,000g for 15 min at 2 °C for cell debris removal and the supernatant containing 
soluble GST-hCD83ext was used for GST assay and SDS-PAGE. The pellet containing insoluble 
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fraction and cell debris was washed once with PBS, and resuspended in TE/SDS buffer (10 mM 
Tris–HCl, pH 8.0, 1 mM EDTA, 1% SDS) upon boiling for 5-10 min.  The solubilized pellet was 
analyzed using SDS-PAGE as the insoluble fraction. GST assay and SDS-PAGE were performed 
as previously described [63].  
 
3.3 Results and discussion 
3.3.1 Physical characterization 
Operating conditions providing maximum oxygen transfer (i.e. rocking rate and VD) were 
established for the 1D RB and CELL-tainer®, and subsequently used to evaluate kLa, tm, 
nonrecombinant growth characteristics, and recombinant protein expression. A comparison of 
kLa values over a range of WVs is presented in Figure 3-1. Oxygen transfer efficiency was a 
linear function of WV in the 1D RB, presenting similar kLa values to the STR for 1 L WV. 
Under these conditions the immersion depth of the DO probe was minimal as the platform tilted 
away from the side of the bag in which the probe was inserted. However, excellent linearity was 
obtained when applying Equation 1 to obtain kLa estimates (R2>0.99). Similar kLa values were 
obtained previously for 1D RBs operating at maximum WV [17, 19]. An inherent limitation of 
the 1D RB was the low gas flow capacity due to the type of outlet filter provided, and the 
inability of the heated filter jacket to adequately dry the filter [17]. Enhanced gas flow capacity 
may improve oxygen transfer efficiency in 1D RBs under high agitation. Increasing the gas flow 
rate from 0.25 to 0.5 vvm corresponded to a 14% increase in kLa at moderate rocking speeds 
[37]. However, kLa was weakly dependent on headspace oxygen transfer at low to moderate 
rocking rates while the opposite effect was observed at maximum agitation [17]. 
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An optimal WV of 3 L was observed for the CELL-tainer®, reaching kLa values of nearly 
400 h-1, while maintaining formidable oxygen transfer capacity over all tested conditions (Figure 
3-1). Our data is in range of recently published kLa measurements [20], although discrepancies 
exist with regard to optimal WV. A reduction of kLa with increasing WV is intuitive considering 
the nature of wave development in shallow water. The wave propagates from the corner of the 
bag, shoaling across the length of the bag until the critical height is achieved, resulting in wave 
breakage [40]. As water depth increases with WV, the wave travels farther across the bag before 
slowing down and breaking. Consequently, wave breakage occurs increasingly near the end of 
the bag opposite inception, in turn, reducing the extent of turbulent air entrainment. This 
rationale supports our observations of low optimal WV for both disposable systems. Moreover, 
an earlier study of mass transfer in the CELL-tainer® reported kLa values at 15 L WV that were 
approximately 60% lower compared to the recently published data [39].  Finally, reduction in kLa 
with increasing WV cannot be solely attributed to reduced specific power input given the sharp 
reduction in kLa observed at maximum rocking rate in the CELL-tainer® (Figure 3-2). Optimal 
rocking rates resulting in the maximum kLa at different WVs has been reported elsewhere [20]. 
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Figure 3-1 - Results for comparative kLa analysis. Experimental conditions described in M&M. 
Standard deviations of three experiments are included. 
 
kLa values increased with increasing rocking rate in the 1D RB up to the maximum 
setting of 40 rpm (Figure 3-2). In contrast, a marginal difference was observed between 40 and 
45 rpm in the CELL-tainer® after which kLa values decreased at the maximum setting of 50 rpm 
(Figure 3-2). Maximum rocking rates may prove beneficial for WVs exceeding 10 L as an 
increase in kLa was obtained beyond 40 rpm at 15 L WV [39]. An advantage of 2D RBs, such as 
the CELL-tainer®, over 1D systems is the capacity to process WVs of up to 75% of the total bag 
volume while maintaining high mass transfer [39]. Finally, kLa values were consistent with those 
previously reported for lab-scale STRs [27, 29, 32]. Although atypically low air flow rates were 
employed due to the limitations of the 1D RB, a significant increase in kLa is not expected at 
higher air flow rates as the STR was operating well above the critical impeller speed 
(approximately 290 rpm for this system) [36]. 
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Figure 3-2 - Results for comparative kLa analysis. 5 L and 2.5 L WV in 1D RB and CELL-
tainer®, respectively. Experimental conditions for 1D RB: 20 L cultivation bag, 35 °C, 0.1 vvm 
air, and 12° VD. Experimental conditions for CELL-tainer® described in M&M. Standard 
deviations of two experiments are included. 
 
Effective mixing was observed in all three systems investigated using water and CMC 
solution (Figure 3-3). tm estimates were consistent with previously reported data using 1D RBs 
[8, 37]. A strong dependence on WV was observed at low rocking rates, although, consistent 
with our observation, tm was independent of WV as rocking rate increased [37]. For the CELL-
tainer®, our tm results were in good agreement with recent studies [20, 61], in which minimal 
dependence of tm on WV was observed. In addition, our tm estimates were in good agreement 
with previous studies of mixing intensity in lab-scale STRs [36, 60]. Comparison of tm associated 
with water and aqueous CMC allows qualitative comparison of the relative shear stress applied 
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in a reactor due to the pseudoplastic nature of CMC. tm of water was shorter than that of CMC 
solution for the 1D RB, while the opposite trend was observed in the CELL-tainer® (Figure 3-3). 
This suggests that greater shear stress may be applied to the fluid in the CELL-tainer® relative to 
the 1D RB under experimental conditions, as tm is often a function of liquid viscosity [103, 104]. 
For STRs, it is well known that local shear stress at the impeller tip is significantly higher than 
the average value [105], and therefore is expected to exceed that of disposable RBs. Shear stress 
is typically not a concern when cultivating E. coli [106], although it has been implicated in the 
reduction of product formation in recombinant E. coli [107, 108]. In such a case, one may benefit 
from reducing the rocking rate without sacrificing adequate oxygen transfer efficiency in RBs.  
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Figure 3-3 - Results for comparative tm analysis. Experimental conditions described in M&M. 
DI water (Panel A) and 0.5% CMC (Panel B). Standard deviations of three experiments are 
included. 
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3.3.2 BL21cultivation and GST-hCD83ext expression 
In addition to evaluating cultivation systems under typical operating conditions and large WV, it 
was interesting to compare culture performance between the STR and 1D RB under comparable 
kLa values (Figure 3-4). A steep decline in DO during early exponential phase resulted in oxygen 
limitation which, in turn, caused significant undesired metabolite accumulation and retarded cell 
growth. Interestingly, the maximum specific growth rate (µmax) for STR cultivation was 18.5% 
higher than that for 1D RB (0.88 vs. 0.74 h-1) although, as shown in Table 3-1, oxygen uptake 
was typically more effective in the 1D RB in the higher DO range (i.e. 50-100% saturation). The 
lower specific OUR measured in the STR in this range can be partially due to surface aeration 
from residual oxygen in the headspace, which can contribute significantly to oxygen transfer in 
smaller vessels [109].  
Note that the influence of antifoam addition on culture performance should be considered 
(Figure 3-4). The kLa value decreased by 45% upon addition of antifoam in a recent study of 
yeast cultivation in the GE WAVE Bioreactor® [17], while a smaller reduction (30%) was 
observed in an STR [110]. These findings are not surprising considering the mode of oxygen 
transfer in RBs, and explain, in part, the difference in DO profiles observed in Figure 3-4. 
Increasing culture viscosity was shown to inhibit wave development in the BIOSTAT® CultiBag 
RM [111], although viscosity likely had minor influence on oxygen transfer at low cell density. 
Consequently, the reliability of kLa estimation at low WV due to superficial probe immersion 
depth was, once again, called into question. Based on our observations, and lack of available data 
for comparison of kLa at minimum WV, further investigation is required to identify the cause(s) 
of severe oxygen limitation under experimental conditions. 
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Figure 3-4 - Typical results for cultivation of E. coli BL21 in the 1D RB (Panels A and B) and 
STR (Panels C and D). Cell density and dissolved oxygen (Panels A and C), and metabolite and 
glucose profiles (Panels B and D). 1 L WV in the 1D RB and 0.4 vvm air.  All other cultivation 
conditions described in M&M. 
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Table 3-1 - Typical results for cultivation of E. coli BL21 in the 1D RB, CELL-tainer®, and 
STR. 5 L and 10 L WV in 1D RB and CELL-tainer®, respectively.  All other cultivation 
conditions described in M&M.  Maximum specific growth rate (µmax) was observed during the 
first 5-6 h of cultivation. Minimum and maximum specific OUR measured over DO range of 20-
50% and 50-100% saturation, respectively. Linear regression errors are included. 
 
 
The results of full-scale non-recombinant E. coli cultivation are presented in Figure 3-5. 
As expected, oxygen limitation ensues quickly in the 1D RB after which DO is rescued 
temporarily upon increasing inlet oxygen supply to 60 vol% at 8.5 h. Cell density was not 
significantly affected under oxygen limitation during which acetate titer reached 6.9 g/L after 
only 11 h. Comparing Figures 3-4b and 3-5b, markedly different glucose consumption patterns 
were evident, indicating improved oxygen availability for 5 L cultivation. This is not unexpected 
as a 2.5-fold increase in available oxygen could offset the 65% decrease in the kLa from 1 to 5 L 
WV [17]. Moreover, the accumulation of various metabolite byproducts (including acetate, 
lactate, and ethanol) was higher after 12 h cultivation at 1 L WV as compared to the 5 L batch. 
Cultivation in the CELL-tainer® produced completely different DO and metabolite profiles, 
although only slight differences in µmax, specific OUR, and cell density were observed. Acetate 
production was merely 2 g/L and all other metabolites were essentially undetectable, 
corresponding to DO exceeding 110% saturation for the entire culture. Comparing Figures 3-5d 
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and 3-5f, glucose consumption occurred at a slower rate during cultivation in the CELL-tainer® 
and faster biomass accumulation was observed in the STR, potentially due to higher oxygen 
availability in the CELL-tainer®. Previous studies have demonstrated that the effects of excess 
DO on the growth of E. coli are strain-dependent. For examples, strains TB-1 [84], W3110 [85], 
and MG1655 [86] exhibited minimal change in growth rate in oxygen-enriched culture. In 
contrast, in accordance with our observations of BL21, the growth rate of JM101 declined at 
high DO [84]. Up to approximately 7 h of cultivation, the growth was similar in the STR and 
CELL-tainer®, after which biomass accumulation slowed as DO increased in the CELL-tainer®, 
while growth rate was maintained with decreasing DO in the STR. 
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Figure 3-5 - Typical results for cultivation of non-recombinant BL21 in the 1D RB (Panels A 
and B), CELL-tainer® (Panels C and D), and STR (Panels E and F). Cell density and dissolved 
oxygen (Panels A, C, and E), and metabolite and glucose profiles (Panels B, D, and F). 5 L and 
10 L WV in the 1D RB and CELL-tainer®, respectively.  All other cultivation conditions 
described in M&M. 
Our investigation reveals that the CELL-tainer® is suitable for batch operation at a 
relatively high growth rate, while the mass transfer capacity of the 1D RB was inadequate under 
current experimental conditions. Although growth characteristics were quite similar, acetate 
accumulation in the 1D RB exceeded levels shown to significantly reduce growth rate [72], 
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potentially compromising cell physiology. The use of the GE WAVE Bioreactor® in generating 
seed culture for a production fermenter was demonstrated at reduced growth rate (0.42 h-1), 
resulting in delayed oxygen depletion relative to our study [18]. Additionally, fed-batch 
cultivation has proven feasible in the BIOSTAT® CultiBag RM, yielding a moderate cell density 
of 20 g/L dry cell weight (dcw) at 5 L WV [19]. A higher biomass yield (42.8 g/L dcw) was 
obtained in 12 L fed-batch cultivation in the CELL-tainer® and 10-fold scale-up resulted in 
similar cell density (45 g/L dcw) even though gas flow was only 10% of that employed in 12 L 
culture due to prototype limitations [20]. 
As shown in Figures 3-6 and 3-7, culture performance was rather comparable in all 
bioreactors. SDS-PAGE confirmed the presence of the GST-hCD83ext fusion (Figure 3-7) and 
corroborated the trends observed for specific GST activity (Figure 3-6). Previously, it was 
reported that specific GST activity peaked at approximately 6 h post-induction coinciding with 
accumulation of the insoluble GST-hCD83ext [63]. Our current results generally agree with 
these observations, although the formation of insoluble GST-hCD83ext appeared less significant. 
The increase in specific GST activity and decrease of insoluble protein could be, in part, due to 
the efficacy of cell lysis at reduced sample concentration. Interestingly, during CELL-tainer® 
cultivation specific GST activity increased slightly from 6 to 8 h post-induction, resulting in a 
16% increase in volumetric GST activity. Specific and volumetric GST activities were similar 
between disposable RBs, although the specific GST activity peaked earlier in the 1D RB. 
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Figure 3-6 - Typical results for cultivation of BL21(pGEX2ThCD83ext,pLysS). 5 L and 10 L 
WV in the 1D RB and CELL-tainer®, respectively. All other cultivation conditions described in 
M&M. Cell density (Panel A), DO (Panel B), and specific GST activity (Panel C). 
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Figure 3-7 - Typical results for cultivation of BL21(pGEX2ThCD83ext,pLysS) in the 1D RB 
(Panel A), CELL-tainer™ (Panel B), and STR (Panel C). 5 L and 10 L WV in the 1D RB and 
CELL-tainer®, respectively. All other cultivation conditions described in M&M. SDS-PAGE 
analysis of soluble and insoluble intracellular protein fractions postinduction. 
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Compared to a previous bioprocess development study [63], a 36% increase in specific 
GST activity with similar cell growth characteristics was observed in the current study. It was 
previously hypothesized that a critical balance exists between GST-hCD83ext expression and 
DO. Recombinant protein expression in oxygen-enriched cultures has been studied extensively 
[84, 85, 89, 90], and excess DO is often associated with lower specific protein yields. Under 
conditions of severe oxidative stress, E. coli may be unable to reduce oxygen radicals (i.e., O2-, 
H2O2, etc.) sufficiently to prevent oxidation of Met and Cys residues [83], potentially resulting in 
protein misfolding, loss of activity, and protease degradation [87, 88]. Considering that 
hCD83ext contains five Cys residues known to cause protein structural variability and instability 
under oxidative conditions [112], varying levels of oxidative stress could partially explain 
differences in protein expression between cultivations. However, the recently observed increase 
in specific GST activity relative to previous studies without oxygen enrichment suggests other 
factors could be at play. A side note to oxidative stress in our cultivations concerns a natural 
function of GST, which reduces organic hydroperoxides using glutathione as electron donor 
[113], a process natively facilitated by alkylhydroperoxide reductase (Ahp) in E. coli [83]. 
Hence, oxidative stress response could be potentially bolstered in E. coli upon GST 
overexpression under our cultivation conditions.  
 
3.4 Conclusions 
In this study, we explored the application of RBs for bacterial cultivation. The results suggest 
that shear stress and DO mildly affects recombinant GST-hCD83ext expression during E. coli 
cultivation in the CELL-tainer®, consistent with our earlier studies using STR. Note that the 
accumulation of undesirable metabolites such as acetate was minimal for cultivations using 
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enriched media with low glucose concentrations. While both 1D and 2D disposable RBs proved 
feasible for E. coli cultivation for recombinant GST-hCD83ext production, the CELL-tainer® 
afforded greater flexibility in terms of operating conditions. However, the use of moderate 
oxygen with extreme agitation (i.e. VD and rocking rate corresponding to maximum kLa) was 
excessive for recombinant protein production. Accordingly, potential oxidative and shear stresses 
could be significantly alleviated under optimized conditions of oxygen supply and agitation. 
Such bioreactor operation and control strategies can be critical, particularly for the production of 
therapeutics, which are often unstable under oxidative conditions. In summary, disposable RBs 
present great opportunity for microbial cultivation compared to conventional STRs, particularly 
for production of high value therapeutics requiring strenuous validation and our study provides 
valuable insight for future biopharmaceutical bioprocess development. 
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Chapter 4 – Conclusions and Recommendations 
 
4.1 Conclusions 
The comparative analysis presented herein demonstrates the utility of disposable RBs in 
obtaining typical biomass yields and high level recombinant protein expression in batch cultures. 
kLa values in the CELL-tainer® were 2.7 and 4.5-fold higher for optimal and maximum WV, 
respectively, compared to the 1D RB; the kLa was 1.5-fold higher at maximum WV compared to 
the STR. kLa at maximum WV (5 L) in the 1D RB was consistent with earlier studies. Maximum 
kLa in the CELL-tainer® was in range of recently reported data, although discrepancies exist 
with regard to optimal WV (12 L in the previous study). Based on large discrepancies in kLa 
values for 15 L WV between the aforementioned study and an earlier investigation, and upon 
consideration of the nature of wave development in shallow water, it is believed that our 
observations of low optimal WV corresponding to maximum kLa are more reliable. Fast mixing 
was observed in all three systems, each providing t95 values of less than 20 s in water and 
aqueous CMC solution under experimental conditions. Comparison of tm in water and aqueous 
CMC solution indicated that shear stress was greater in the CELL-tainer® relative to the 1D RB. 
The 1D RB and CELL-tainer® produced comparable cell densities and recombinant hCD83ext 
yields relative to the conventional STR. In the 1D RB, cell growth was severely hindered without 
supplemental oxygen in 1 L culture, and acetate accumulation was excessive for 5 L 
nonrecombinant cultivation regardless of inlet oxygen concentration. Biomass accumulation and 
glucose consumption occurred at a faster rate in the STR relative to the CELL-tainer®, possibly 
due to enhanced mass transfer given that the growth rate of BL21 was inhibited by elevated DO. 
Variations in hCD83ext expression between bioreactors were attributed to significant differences 
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in DO profiles, and possibly shear stress. In the CELL-tainer®, reduced oxygen and/or agitation 
could potentially enhance growth characteristics and protein expression, and improve process 
efficiency via reduced oxygen and power consumption. While hCD83ext expression and cell 
growth in the 1D RB were comparable to other systems, the use of oxygen for low cell density 
cultures is not desirable in the context of process scale-up given that other cultivation systems 
are capable of meeting the relatively low oxygen demand without oxygen enrichment. On the 
other hand, the CELL-tainer® provides mass transfer capacity similar to the STR, and improved 
efficiency with respect to specific power input compared to 1D RBs. Accordingly, the CELL-
tainer® presents new opportunities for cost reduction in biopharmaceutical manufacturing 
processes based on microbial platforms, and provides versatility to multiproduct facilities 
utilizing prokaryotic and shear sensitive eukaryotic expression hosts.  
 
4.2 Recommendations 
The utility of disposable RBs for cultivation of E. coli, a robust aerobic organism, to achieve 
high level expression of a eukaryotic therapeutic protein was successfully demonstrated. While 
protein expression and cell density were comparable between the 1D RB, CELL-tainer®, and 
conventional STR, the low mass transfer capacity of the 1D RB barely met the relatively low 
oxygen demand of batch cultures, even with supplemental oxygen. 1D RBs are, therefore, not 
recommended for cultivation of fast growing aerobic microorganisms given the current 
limitations of these systems. Fed-batch cultivation in 1D RBs has been investigated in an earlier 
study [19], although oxygen demand at moderate cell density (20 g/L dcw) and low growth rate 
(< 0.15 h-1) exceeded mass transfer capacity. As previously discussed, higher gas flow capacity 
may significantly increase the kLa at high agitation rates in 1D RBs. Therefore, it is 
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recommended that 1D RBs evolve with improved gas flow capacity if biopharmaceutical 
production in microbial expression hosts is a target application.  
 The CELL-tainer®, on the other hand, shows promise as a cultivation system for the full 
range of recombinant expression hosts, demonstrating comparable performance to the STR with 
regard to cell growth, DO profiles, and hCD83ext expression in batch cultures of E. coli. 
Furthermore, the kLa exceeded that of the STR and tm was comparable for all WV. Although 
atypically low air flow rates were employed due to the limitations of the 1D RB, a significant 
increase in kLa is not expected at higher air flow rates as the STR was operating well above the 
critical impeller speed. Subsequent investigations needed to fully characterize the CELL-
tainer®’s performance are outlined: 
1. Fed-batch cultivation of nonrecombinant BL21 (or other robust E. coli strain) under 
typical operating conditions for recombinant protein expression (i.e. 25-30 °C, 30-35 
rpm, 1-1.5 vvm) to establish limits on achievable cell density, and corresponding 
undesirable metabolite profiles and oxygen consumption. Fed-batch cultivation of 
nonrecombinant BL21 has been investigated in the CELL-tainer® , however, cultivation 
temperature (37 °C) greatly exceeded temperatures typically employed during 
recombinant protein production [20]. 
2. Fed-batch cultivation of BL21(pGEX2ThCD83ext, pLysS) to assess the CELL-tainer®’s 
potential in achieving production scale titers of a recombinant therapeutic. hCD83ext is 
an ideal candidate for this type of study due to its sensitivity to oxidative conditions and 
propensity for inclusion body formation. Under the appropriate conditions of oxygen 
enrichment and agitation, the CELL-tainer® may provide certain advantages over STRs 
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for production of oxygen sensitive proteins due to the lack of oxygen hot spots found in 
the vicinity of the sparger(s).   
3. Theoretical modelling of mass transfer and CFD simulations to characterize kLa, tm, 
velocity distribution, wave properties (i.e. H, C, T, L, and θ), liquid height profiles, and 
shear rates. As previously discussed, ε can be approximated via Equation 6 which, in 
turn, can be used to determine kL from Equation 3. The difficulty in this approach is 
obtaining reliable measurements of a, H, and L. In the absence of reliable experimental 
data, CFD modeling could provide predictions of these parameters for a given set of 
operating conditions (i.e. K, VD, and WV). This study would entail a more thorough 
assessment of kLa and tm over a broad range of operating conditions to better characterize 
mass transfer and mixing, and to verify the theoretical model. 
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